What Is Sympathetic Inner Ear Disease?

Autoimmune inner ear disease, often abbreviated as AIED, is a poorly understood condition in which the body's immune system mistakenly targets cells and structures of the inner ear. The older name, sympathetic inner ear disease, comes from an early theory that inflammation in one ear could trigger a similar immune response in the other ear, much like sympathetic ophthalmia affects both eyes after injury to one. Today, AIED is recognised as one of the few causes of rapidly progressive hearing loss that can respond to medical treatment if caught in time.

The term "sympathetic" is still used by some clinicians to describe bilateral hearing loss that appears to follow an inflammatory event in one ear, but modern research suggests that AIED is primarily an autoimmune disorder rather than a direct spread of infection or injury.

Recognising the Symptoms

The hallmark of AIED is hearing loss that develops over weeks or months rather than years. Unlike age-related hearing loss, which is gradual, AIED often progresses noticeably from one week to the next. Many people notice that their hearing fluctuates, with periods of improvement followed by sudden worsening.

Other common symptoms include persistent ringing in the ears, a feeling of fullness or pressure inside the ear, and dizziness or imbalance. Some individuals experience episodes of true vertigo that mimic disorders such as Meniere's disease, making the condition difficult to diagnose from symptoms alone. Hearing loss may affect one ear at first, but in a large proportion of cases it eventually becomes bilateral.

What Causes the Immune System to Attack the Ear?

The exact trigger is unknown. In AIED, the immune system appears to produce antibodies and immune cells that attack proteins within the cochlea, the spiral-shaped hearing organ, or the vestibular system, which controls balance. The endolymphatic sac and other inner ear tissues have also been implicated as targets of this immune response.

Several mechanisms have been proposed. One theory involves cross-reactivity, where the immune system, while fighting an earlier infection, mistakes inner ear proteins for foreign invaders. Another involves a breakdown in self-tolerance, causing the immune system to lose its ability to distinguish healthy ear tissue from harmful pathogens. Genetic factors and viral triggers are also under investigation, but no single cause has been proven.

How Is AIED Diagnosed?

There is no single laboratory test that can confirm AIED. Diagnosis is based on a combination of clinical history, hearing tests, and the exclusion of other causes of sensorineural hearing loss such as head injury, loud noise exposure, drug toxicity, infections, or a tumour on the nerve connecting the ear to the brain.

Audiometric testing is essential, particularly to document the type and degree of hearing loss and to track changes over time. Magnetic resonance imaging is often used to look for masses or swelling within the ear and skull base. Blood tests may be ordered to check inflammatory markers, erythrocyte sedimentation rate, antinuclear antibodies, or other autoantibody panels, though these tests are not specific and can be normal even when AIED is present.

Because of the difficulty of confirming the condition, many clinicians use a trial of corticosteroid medication as a diagnostic tool. A noticeable improvement in hearing during high-dose steroid therapy strongly supports the diagnosis.

Treatment Options

High-dose oral corticosteroids, such as prednisone, remain the first line of treatment for AIED. Early treatment offers the best chance of preserving hearing, and many patients show significant improvement within weeks. Because long-term steroid use is associated with serious side effects, treatment is usually tapered slowly once hearing stabilises.

For individuals who cannot tolerate steroids or who become dependent on high doses, other medications that suppress the immune system may be considered. These include methotrexate, azathioprine, cyclophosphamide, and biologic agents such as rituximab or tumour necrosis factor inhibitors. These drugs carry their own risks and require close monitoring by a specialist familiar with immunosuppressive therapy.

For people who experience severe or profound hearing loss despite medical treatment, hearing aids can be useful. When hearing loss is very severe in both ears, a cochlear implant may be an appropriate option; many recipients of cochlear implants have an AIED diagnosis, and their outcomes are often good.

Outlook and Prognosis

The course of AIED varies widely from person to person. Some individuals lose only a small amount of hearing and recover almost fully with steroids. Others experience a progressive decline that eventually affects both ears despite aggressive treatment.

Prompt diagnosis and early treatment are the most important factors linked to better hearing outcomes. People who delay seeking medical help may develop permanent damage because sustained inflammation can destroy inner ear hair cells and supporting tissues. Ongoing research into biomarkers and more targeted immune therapies aims to improve diagnosis and reduce reliance on medications that affect the whole body.

Anyone who notices sudden or rapidly worsening hearing loss, especially when accompanied by ringing or dizziness, should seek an evaluation by an ear specialist as soon as possible. While AIED is uncommon, it is also one of the few types of hearing loss that medical therapy can sometimes reverse.